First Trust Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,341
Closed -$1.39M 2611
2024
Q4
$1.39M Sell
40,341
-68,117
-63% -$3.07M ﹤0.01% 1948
2024
Q3
$5.36M Sell
108,458
-42
-0% -$2.15K 0.01% 1306
2024
Q2
$6.53M Sell
108,500
-9,551
-8% -$546K 0.01% 1160
2024
Q1
$6.09M Sell
118,051
-10,258
-8% -$504K 0.01% 1206
2023
Q4
$5.17M Buy
+128,309
New +$3.76M 0.01% 1244

Other funds holding RXST

First Trust Advisors's RXST Position: Q1 2025 in Review

First Trust Advisors sold out of RxSight (RXST) in Q1 2025, closing a stake of 40,341 shares — an estimated $1.39M sold.

First Trust Advisors first reported a position in RXST in Q4 2023 and held it in 5 quarters. The position peaked at $6.53M in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • First Trust Advisors reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • First Trust Advisors sold 40,341 RxSight shares in Q1 2025, an estimated $1.39M.
  • First Trust Advisors first reported a position in RxSight in Q4 2023 and held it in 5 quarters.
  • First Trust Advisors's RxSight position peaked at $6.53M in Q2 2024.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on First Trust Advisors's 13F filing for Q1 2025, filed 14 May 2025.